Literature DB >> 1714398

The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways.

M Araie1, D M Maurice.   

Abstract

The pathways by which fluorescein (F), fluorescein glucuronide (FG) and fluorescein dextran (FD) leave the vitreous body of the rabbit were examined by measuring the concentration distribution of the injected fluorophores in sections of the frozen eyes. The contours of F, as already known, show that it leaves the vitreous predominantly across the retinal surface. Mathematical analysis of the concentration gradient leads to an average outward permeability coefficient of 1.4 x 10(-3) cm min-1 for the retinal layers. The contours of FG and FD show that they leave predominantly by diffusion into the posterior chamber, encountering only a minor barrier at the anterior hyaloid membrane. The anterior contours indicate that there can be no substantial posteriorly directed fluid flow through the vitreous; if it occurs its velocity across the retinal surface must be less than 2 x 10(-5) cm min-1. The contours of FD near the posterior pole of the retina suggest that such a flow may be taking place. Some time after the systemic administration of F, an analysis of the rate of loss of fluorescence from the vitreous body shows that this corresponds to the movement of FG out through the anterior chamber. Its value bears little relationship to the condition of the blood-vitreal barrier.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714398     DOI: 10.1016/0014-4835(91)90125-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  26 in total

1.  Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor.

Authors:  Matthew S Stay; Jing Xu; Theodore W Randolph; Victor H Barocas
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Hydraulic flow and vascular clearance influences on intravitreal drug delivery.

Authors:  Paul J Missel
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

3.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

4.  Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways.

Authors:  Marko Lamminsalo; Ella Taskinen; Timo Karvinen; Astrid Subrizi; Lasse Murtomäki; Arto Urtti; Veli-Pekka Ranta
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

5.  Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.

Authors:  Nahid Haghjou; Mohammad J Abdekhodaie; Yu-Ling Cheng
Journal:  Pharm Res       Date:  2012-10-02       Impact factor: 4.200

6.  Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM.

Authors:  B Moldow; M Larsen; B Sander; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

7.  Permeability and diffusion in vitreous humor: implications for drug delivery.

Authors:  J Xu; J J Heys; V H Barocas; T W Randolph
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

8.  Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Authors:  Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Journal:  Brain Res Bull       Date:  2009-09-15       Impact factor: 4.077

9.  Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide).

Authors:  Suk Ho Byeon; Oh W Kwon; Ji Hun Song; Sung Eun Kim; Yong Sik Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

10.  FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.